Psoriasis Treatment Market By Drug Class (TNF Inhibitors, Vitamin D Analogues, Interleukin Blockers, Topical Corticosteroids), By Type (Plaque Psoriasis, Guttate Psoriasis, Flexural Or Inverse Psoriasis, Psoriatic Arthritis) - Growth, Share, Opportunities & Competitive Analysis, 2015 – 2025
Psoriasis is a chronic, inflammatory, painful skin disease; currently there is no cure primary goal of treatment is to reduce inflammation and abnormal skin plaque formation. Psoriasis treatment market is rapidly growing due to factors such as growing prevalence, significant unmet needs, promising pipeline molecules would fuel the growth of psoriasis treatment market worldwide.
The report titled “Psoriasis Treatment Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall psoriasis treatment market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on drug class, type and different geographical regions. Geographically, the global psoriasis treatment market is studied for the following regional markets:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia-Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of LATAM
- Middle East and Africa
- GCC
- Rest of MEA
Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global psoriasis treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global psoriasis treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in global psoriasis treatment market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.
Thus, the research study provides a holistic view of the global psoriasis treatment market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.
Based on drug class, the global psoriasis treatment market is segmented as follows:
- Interleukin Blockers
- Topical Corticosteroids
- Tumor Necrosis Factor (TNF) Inhibitors
- Vitamin D Analogues
- Others
Psoriasis is a chronic, autoimmune inflammatory skin disorder characterized by red patches of abnormal skin. Factors such as increase in prevalence of psoriasis and skin disorders and increase in treatment awareness are driving the growth of psoriasis treatment market globally. The main goal of psoriasis treatment is to reduce inflammation and to stop plaque formation. For the treatment of psoriasis medication generally given by topical, systemic or oral route; along with medication phototherapy alone or in combination with medication is widely accepted in market. Biologics such as Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade), Secukinumab (Cosentyx), Ustekinumab (Stelara), Taltz (ixekizumab) are widely used in market and newly approved biologic Siliq (brodalumab), Tremfya (Guselkumab) expected to drive significant market growth during forecast period. There are different types of medication are used in market, among these interleukin blockers held largest market share in the base year 2016, because interleukin blockers drugs such as ustekinumab, secukinumab, ixekizumab have long-term safety with lower risk of infection and malignancy. Inflammation is associated with psoriasis and thus tumor necrosis factor such as certolizumab pegol, etanercept, adalimumab, infliximab, golimumab, Vitamin D analogue (calcipotriol) and topical corticosteroids are commonly used in market. Other medication such as retinoids, calcineurin inhibitors and cyclosporine are used to reduce a plaque formation.
Based on type, the global psoriasis treatment market is segmented as follows:
- Plaque psoriasis
- Guttate psoriasis
- Flexural or inverse psoriasis
- Psoriatic arthritis
- Others
Psoriasis is a chronic, autoimmune inflammatory skin disorder characterized by red patches of abnormal skin. Factors such as increase in incidence of psoriasis and skin disorders, increase in treatment awareness and wide availability of treatment medications are driving the growth of psoriasis treatment market globally. The main goal of psoriasis treatment is to reduce inflammation and to stop plaque formation. Psoriasis treatment market is segmented on the basis of type such as plaque, guttate, flexural or inverse, psoriatic arthritis and other type of psoriasis. It is observed that plaque psoriasis is major revenue generating segment because plaque psoriasis is most common form of psoriasis and affects more 85%–90% of people with psoriasis, approximately 2%-3% of population of the United States is affected with plaque psoriasis. There are different types of medication such as vitamin D analogue, topical retinoids, tazarotene are widely used in market.
For the purpose of this study, the global psoriasis treatment market is categorized into:
- North America
- Europe
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
Psoriasis is a chronic, noncommunicable, painful skin disease for which there is no cure with great negative impact on patients quality of life, it can occur at any age, but more common older people. According to the International Federation of Psoriasis Associations (IFPA), about 3 percent of the world’s population has some form of psoriasis. In the base year 2016, North America dominated the psoriasis treatment market, United States is largest revenue contributor due to the upsurge in funding by government agencies and private organizations in healthcare system, higher cost of medication, higher number of psoriasis patient are factors fueling growth of psoriasis treatment market. According to the Cleveland Clinic, there are about 150,000 new cases of psoriasis every year in United States, approximately 2 percent of U.S. population is affected with psoriasis. Europe is the second largest revenue generating regional market for psoriasis treatment due to higher number of psoriasis patient have been reported in some European region such as Faroe Islands where about 2.8% of the population is affected with psoriasis. It is observed that, currently Asia Pacific is hold smallest market share due to the factors such as lowest Incidence rate in some countries such as japan, Australia, China, India; also comparatively lower cost of medication may hinder the growth of psoriasis treatment market in Asia Pacific.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Psoriasis Treatment Market Snapshot
2.2 Global Psoriasis Treatment Market, Drug Class
2.3 Global Psoriasis Treatment Market, Type
2.4 Global Psoriasis Treatment Market Share, by Geography, 2016 (Value %)
Chapter 3 Psoriasis Treatment Market Analysis
3.1 Global Psoriasis Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Pipeline Analysis in Psoriasis Treatment Market
3.4 Global Epidemiology Data for Psoriasis
3.5 Comparative study of Psoriasis Therapeutics
3.5.1 Tremfya (Guselkumab)
3.5.2 Siliq (Brodalumab)
3.5.3 Taltz (Ixekizumab)
3.6 Attractive Investment Proposition
3.7 Competitive Landscape of Key Players in Psoriasis Treatment Market
Chapter 4 Global Psoriasis Treatment Market, by Drug Class
4.1 Overview
4.2 Top 3 Countries
4.3 TNF Inhibitors
4.4 Vitamin D Analogues
4.5 Interleukin Blockers
4.6 Topical Corticosteroids
4.7 Other
Chapter 5 Global Psoriasis Treatment Market, by Type
5.1 Overview
5.2 Top 3 Countries
5.3 Plaque psoriasis
5.4 Guttate psoriasis
5.5 Flexural or inverse psoriasis
5.6 Psoriatic arthritis
5.7 Other
Chapter 6 Global Psoriasis Treatment Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.2.1 North America Psoriasis Treatment Market, by Drug Class, 2015- 2025 (US$)
6.2.2 North America Psoriasis Treatment Market, by Type, 2015- 2025 (US$)
6.2.3 North America Psoriasis Treatment Market, by Country, 2015- 2025 (US$)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Psoriasis Treatment Market, by Drug Class, 2015- 2025 (US$)
6.3.2 Europe Psoriasis Treatment Market, by Type, 2015- 2025 (US$)
6.3.3 Europe Psoriasis Treatment Market, by Country, 2015- 2025 (US$)
6.4 Asia Pacific (China, Japan and Rest of APAC)
6.4.1 Asia Pacific Psoriasis Treatment Market, by Drug Class, 2015- 2025 (US$)
6.4.2 Asia Pacific Psoriasis Treatment Market, by Type, 2015- 2025 (US$)
6.4.1 Asia Pacific Psoriasis Treatment Market, by Country, 2015- 2025 (US$)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Psoriasis Treatment Market, by Drug Class, 2015- 2025 (US$)
6.5.2 Latin America Psoriasis Treatment Market, by Type, 2015- 2025 (US$)
6.5.3 Latin America Psoriasis Treatment Market, by Country, 2015- 2025 (US$)
6.6 Middle East and Africa (GCC and Rest of MEA)
6.6.1 Middle East and Africa Psoriasis Treatment Market, by Drug Class, 2015- 2025 (US$)
6.6.2 Middle East and Africa Psoriasis Treatment Market, by Type, 2015- 2025 (US$)
6.6.3 Middle East and Africa Psoriasis Treatment Market, by Country, 2015- 2025 (US$)
Chapter 7 Company Profiles
7.1 AbbVie Inc.
7.2 Amgen Inc.
7.3 AstraZeneca
7.4 Biogen
7.5 Boehringer Ingelheim
7.6 Celgene
7.7 Eli Lilly and Company
7.8 Johnson & Johnson
7.9 LEO Pharma A/S
7.10 Merck & Co., Inc.
7.11 Novartis AG
7.12 Pfizer, Inc.
7.13 Stiefel Laboratories Inc. (GlaxoSmithKline plc)
7.14 Sun Pharmaceutical Industries
TABLE 1 Market Positioning of Key Players in Global Psoriasis Treatment Market
TABLE 2 Global Psoriasis Treatment Market, by Drug Class, 2015 – 2025 (US$ Bn)
TABLE 3 Top 3 Countries in Global Psoriasis Treatment Market, 2015 – 2025 (US$ Bn)
TABLE 4 Global Psoriasis Treatment Market, by Type, 2015 – 2025 (US$ Bn)
TABLE 5 Top 3 Countries in Global Psoriasis Treatment Market, 2015 – 2025 (US$ Bn)
TABLE 6 Global Psoriasis Treatment Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 7 North America Psoriasis Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 8 North America Psoriasis Treatment Market, by Type, 2015-2025 (US$ Bn)
TABLE 9 North America Psoriasis Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 10 Europe Psoriasis Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 11 Europe Psoriasis Treatment Market, by Type, 2015-2025 (US$ Bn)
TABLE 12 Europe Psoriasis Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 13 Asia Pacific Psoriasis Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 14 Asia Pacific Psoriasis Treatment Market, by Type, 2015-2025 (US$ Bn)
TABLE 15 Asia Pacific Psoriasis Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 16 Latin America Psoriasis Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 17 Latin America Psoriasis Treatment Market, by Type, 2015-2025 (US$ Bn)
TABLE 18 Latin America Psoriasis Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 19 Middle East and Africa Psoriasis Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 20 Middle East and Africa Psoriasis Treatment Market, by Type, 2015-2025 (US$ Bn)
TABLE 21 Middle East and Africa Psoriasis Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 22 AbbVie Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 23 Amgen Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 24 AstraZeneca: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 25 Biogen: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 26 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 27 Celgene: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 28 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 29 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 30 LEO Pharma A/S: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 31 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 32 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 33 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 34 Stiefel Laboratories Inc. (GlaxoSmithKline plc): Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 35 Sun Pharmaceutical Industries: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
FIG. 1 Psoriasis Treatment Market: Research Methodology
FIG. 2 Global Psoriasis Treatment Market, by Drug Class, 2016 (US$ Bn)
FIG. 3 Global Psoriasis Treatment Market, by Type, 2016 (US$ Bn)
FIG. 4 Global Psoriasis Treatment Market Share, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition: Global Psoriasis Treatment Market, by Geography, 2016
FIG. 6 Global TNF Inhibitors Market, 2015 – 2025 (US$ Bn)
FIG. 7 Global Vitamin D Analogues Market, 2015 – 2025 (US$ Bn)
FIG. 8 Global Interleukin Blockers Market, 2015 – 2025 (US$ Bn)
FIG. 9 Global Topical Corticosteroids Market, 2015 – 2025 (US$ Bn)
FIG. 10 Global Other Psoriasis Medication Market, 2015 – 2025 (US$ Bn)
FIG. 11 Global Plaque Psoriasis Market, 2015 – 2025 (US$ Bn)
FIG. 12 Global Guttate Psoriasis Market, 2015 – 2025 (US$ Bn)
FIG. 13 Global Flexural or Inverse Psoriasis Market, 2015 – 2025 (US$ Bn)
FIG. 14 Global Psoriatic Arthritis Market, 2015 – 2025 (US$ Bn)
FIG. 15 Global Other Types of Psoriasis Market, 2015 – 2025 (US$ Bn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)